CY1124605T1 - Ζωα με εξανθρωπισμενα il-4 και il-4r αλφα - Google Patents

Ζωα με εξανθρωπισμενα il-4 και il-4r αλφα

Info

Publication number
CY1124605T1
CY1124605T1 CY20211100805T CY211100805T CY1124605T1 CY 1124605 T1 CY1124605 T1 CY 1124605T1 CY 20211100805 T CY20211100805 T CY 20211100805T CY 211100805 T CY211100805 T CY 211100805T CY 1124605 T1 CY1124605 T1 CY 1124605T1
Authority
CY
Cyprus
Prior art keywords
human
gene
animals
humanized
human animals
Prior art date
Application number
CY20211100805T
Other languages
English (en)
Inventor
Li-Hsien Wang
Yingzi Xue
Andrew J. Murphy
Sean Stevens
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of CY1124605T1 publication Critical patent/CY1124605T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New breeds of animals
    • A01K67/027—New breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Humanized animals, e.g. knockin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/20—Animal model comprising regulated expression system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0368—Animal model for inflammation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0393—Animal model comprising a reporter system for screening tests

Abstract

Παρέχονται μη ανθρώπινα ζώα που περιλαμβάνουν μια αλληλουχία ανθρώπινου ή εξανθρωπισμένου νουκλεϊκού οξέος IL-4/ή IL-4Rα. Περιγράφονται μη ανθρώπινα ζώα που περιλαμβάνουν μια αντικατάσταση του ενδογενούς γονιδίου IL-4 ή/και γονιδίου IL-4Rα από ένα ανθρώπινο γονίδιο IL-4 ή/και γονίδιο IL-4Rα εν όλω ή εν μέρει καθώς και μέθοδοι δημιουργίας και χρήσης των μη ανθρώπινων ζώων. Παρέχονται, επίσης, μη ανθρώπινα ζώα που αποτελούνται από ένα ανθρώπινο ή εξανθρωπισμένο γονίδιο IL-4 υπό τον έλεγχο των ρυθμιστικών στοιχείων μη ανθρώπινης IL-4, συμπεριλαμβανομένων μη ανθρώπινων ζώων που έχουν μια αντικατάσταση μη ανθρώπινης αλληλουχίας κωδικοποίησης IL-4 από ανθρώπινη αλληλουχία κωδικοποίησης IL-4 σε έναν ενδογενή γονιδιακό τόπο μη ανθρώπινης IL-4. Παρέχονται, επίσης, μη ανθρώπινα ζώα που αποτελούνται από ένα ανθρώπινο ή εξανθρωπισμένο γονίδιο IL-4Rα υπό τον έλεγχο των ρυθμιστικών στοιχείων μη ανθρώπινου IL-4Rα, συμπεριλαμβανομένων μη ανθρώπινων ζώων που έχουν μια αντικατάσταση μη ανθρώπινης αλληλουχίας κωδικοποίησης IL-4Rα από μια ανθρώπινη ή εξανθρωπισμένη αλληλουχία κωδικοποίησης IL-4Rα σε έναν ενδογενή γονιδιακό τόπο μη ανθρώπινου C IL-4Rα. Παρέχονται μη ανθρώπινα ζώα που περιλαμβάνουν ανθρώπινο ή εξανθρωπισμένο γονίδιο IL-4 ή/και αλληλουχίες IL-4Rα, όπου τα μη ανθρώπινα ζώα είναι τρωκτικά, π.χ. ποντικοί ή αρουραίοι.
CY20211100805T 2014-05-07 2021-09-14 Ζωα με εξανθρωπισμενα il-4 και il-4r αλφα CY1124605T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461989757P 2014-05-07 2014-05-07
PCT/US2015/029638 WO2015171861A1 (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals
EP15727106.5A EP3027015B1 (en) 2014-05-07 2015-05-07 Humanized il-4 and il-4r alpha animals

Publications (1)

Publication Number Publication Date
CY1124605T1 true CY1124605T1 (el) 2022-07-22

Family

ID=53284509

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20181100040T CY1119773T1 (el) 2014-05-07 2018-01-15 Ανθρωποποιημενα il-4 και il-4r αλφα ζωα
CY20211100805T CY1124605T1 (el) 2014-05-07 2021-09-14 Ζωα με εξανθρωπισμενα il-4 και il-4r αλφα

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20181100040T CY1119773T1 (el) 2014-05-07 2018-01-15 Ανθρωποποιημενα il-4 και il-4r αλφα ζωα

Country Status (25)

Country Link
US (7) US9565841B2 (el)
EP (3) EP3906781A1 (el)
JP (4) JP6640740B2 (el)
KR (2) KR102473565B1 (el)
CN (2) CN106470545B (el)
AU (2) AU2015255977B2 (el)
BR (1) BR112016025745A2 (el)
CA (2) CA2947307C (el)
CY (2) CY1119773T1 (el)
DK (2) DK3027015T3 (el)
ES (2) ES2656529T3 (el)
HR (2) HRP20211455T1 (el)
HU (2) HUE038028T2 (el)
IL (3) IL297105B2 (el)
LT (2) LT3027015T (el)
MX (1) MX370672B (el)
NO (1) NO2785538T3 (el)
PH (1) PH12016502058A1 (el)
PL (2) PL3027015T3 (el)
PT (2) PT3027015T (el)
RS (2) RS62345B1 (el)
RU (1) RU2703139C2 (el)
SG (2) SG10201912354PA (el)
SI (2) SI3281521T1 (el)
WO (1) WO2015171861A1 (el)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2785538T3 (el) 2014-05-07 2018-08-04
PL3157956T3 (pl) 2014-06-19 2020-06-29 Regeneron Pharmaceuticals, Inc. Zwierzęta inne niż człowiek mające humanizowany gen zaprogramowanej śmierci komórkowej 1
JP6899322B2 (ja) * 2014-09-17 2021-07-07 エリコン・サーフェス・ソリューションズ・アクチェンゲゼルシャフト，プフェフィコーンＯｅｒｌｉｋｏｎ Ｓｕｒｆａｃｅ Ｓｏｌｕｔｉｏｎｓ Ａｇ， Ｐｆａｅｆｆｉｋｏｎ 改善された耐摩耗性を有する２層コーティングされた切削工具を製造するための方法
ES2844000T3 (es) 2014-11-24 2021-07-21 Regeneron Pharma Animales no humanos que expresan el complejo CD3 humanizado
KR102313073B1 (ko) 2014-12-05 2021-10-18 리제너론 파마슈티칼스 인코포레이티드 인간화 분화 클러스터 47 유전자를 가진 비인간 동물
WO2017087780A1 (en) 2015-11-20 2017-05-26 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized lymphocyte-activation gene 3
MX2018009513A (es) 2016-02-04 2019-01-31 Regeneron Pharma Animales no humanos que tienen un gen angptl8 modificado genéticamente.
RU2749715C2 (ru) 2016-02-29 2021-06-16 Регенерон Фармасьютикалз, Инк. Грызуны, характеризующиеся гуманизированным геном tmprss
TWI784988B (zh) * 2016-12-01 2022-12-01 美商再生元醫藥公司 治療發炎症狀的方法
KR20230164197A (ko) 2017-04-13 2023-12-01 리제너론 파마슈티칼스 인코포레이티드 Il33 및 il1rl1을 코딩하는 유전자에서의 위험 대립유전자를 갖는 환자에서의 폐 질환의 치료 및 저해
EP3638697A4 (en) 2017-06-12 2021-07-07 Bluefin Biomedicine, Inc. ANTI-IL1RAP ANTIBODIES AND ANTIBODY INGREDIENT CONJUGATES
JP7361031B2 (ja) 2017-11-30 2023-10-13 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物
SG11202008620VA (en) 2018-03-26 2020-10-29 Regeneron Pharma Humanized rodents for testing therapeutic agents
IL307286A (en) 2018-04-11 2023-11-01 Regeneron Pharma Methods and preparations for quantification of IL-33
JP7048051B2 (ja) 2018-07-11 2022-04-05 正徳 染井 痒みを軽減するアトピー性皮膚炎治療剤
EP3823443A1 (en) 2018-07-16 2021-05-26 Regeneron Pharmaceuticals, Inc. Non-human animal models of ditra disease and uses thereof
WO2020074005A1 (en) * 2018-10-12 2020-04-16 Beijing Biocytogen Co., Ltd Genetically modified non-human animal with human or chimeric genes
WO2020147829A1 (zh) * 2019-01-17 2020-07-23 北京百奥赛图基因生物技术有限公司 人源化转基因动物
JP2022528414A (ja) 2019-04-04 2022-06-10 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化凝固因子１２遺伝子座を含む非ヒト動物
JP2022534867A (ja) 2019-06-04 2022-08-04 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ベータスリップ変異を有するヒト化ｔｔｒ遺伝子座を含む非ヒト動物と使用方法
TW202112229A (zh) 2019-06-07 2021-04-01 美商雷傑納榮製藥公司 包含人化白蛋白基因座之非人的動物
CN112300265B (zh) * 2019-07-29 2022-09-27 百奥赛图(北京)医药科技股份有限公司 Il33基因人源化的非人动物的构建方法和应用
US20220312749A1 (en) * 2019-08-09 2022-10-06 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric il2ra
US20220378025A1 (en) * 2019-11-11 2022-12-01 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric genes
US20220354097A1 (en) * 2019-12-25 2022-11-10 Gempharmatech Co., Ltd. Il-15 humanized mouse model and use thereof
JP2023511626A (ja) * 2020-01-28 2023-03-20 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化ｐｎｐｌａ３遺伝子座を含む非ヒト動物および使用方法
CN111149767B (zh) * 2020-02-24 2021-07-20 中南大学湘雅二医院 一种人源化皮肤型红斑狼疮小鼠模型的构建方法和应用
CN113527485A (zh) 2020-04-17 2021-10-22 上海麦济生物技术有限公司 抗人白细胞介素-4受体α抗体及其制备方法和应用
CN111808882B (zh) * 2020-09-01 2020-12-29 北京百奥赛图基因生物技术有限公司 Il7r基因人源化改造的动物模型的构建方法及其应用
CN111793646B (zh) * 2020-09-08 2021-01-15 北京百奥赛图基因生物技术有限公司 Il1r1基因人源化改造的非人动物的构建方法及其应用
CN111926039B (zh) * 2020-09-23 2021-03-16 百奥赛图(北京)医药科技股份有限公司 Il-13基因人源化的非人动物的构建方法和应用
WO2022140221A1 (en) * 2020-12-21 2022-06-30 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized tslp gene, a humanized tslp receptor gene, and/or a humanized il7ra gene
CN114835798B (zh) * 2021-05-28 2024-02-23 百奥赛图(北京)医药科技股份有限公司 Cd36基因人源化非人动物的构建方法及应用
WO2024067796A1 (zh) * 2022-09-28 2024-04-04 百奥赛图(北京)医药科技股份有限公司 一种il5和/或il5ra基因人源化修饰的非人动物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990005183A1 (en) * 1988-10-31 1990-05-17 Immunex Corporation Interleukin-4 receptors
SI1802193T1 (sl) 2004-10-19 2014-08-29 Regeneron Pharmaceuticals, Inc. Postopek za generiranje miši, homozigotne za genetsko modifikacijo
JP2007252370A (ja) * 2006-02-22 2007-10-04 Institute Of Physical & Chemical Research Ｉｌ−４初期発現系トランスジェニック非ヒト動物およびその利用
US20110016543A1 (en) * 2008-12-04 2011-01-20 Sigma-Aldrich Co. Genomic editing of genes involved in inflammation
SG176118A1 (en) * 2009-06-29 2011-12-29 Qingfeng Chen Methods of producing humanized non-human mammals
KR20120097483A (ko) * 2009-07-24 2012-09-04 시그마-알드리치 컴퍼니., 엘엘씨 게놈 편집을 위한 방법
RU2425880C2 (ru) * 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Способ получения трансгенных мышей
EP3056082B1 (en) 2009-10-06 2018-09-05 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
CN105861553B (zh) 2011-02-15 2020-08-14 再生元制药公司 人源化m-csf小鼠
HUE048511T2 (hu) 2011-10-28 2020-07-28 Regeneron Pharma Kiméra fõ hisztokompatibilitási komplex (MHC) II molekulákat expresszáló, genetikailag módosított egerek
SG10202100485XA (en) * 2011-10-28 2021-02-25 Regeneron Pharma Humanized il-6 and il-6 receptor
RS59082B1 (sr) 2011-10-28 2019-09-30 Regeneron Pharma Miševi sa genetski modifikovanim glavnim kompleksom gena tkivne podudarnosti
US8962913B2 (en) * 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
PT4011915T (pt) * 2012-08-21 2024-01-02 Regeneron Pharma Métodos para o tratamento ou prevenção da asma através da administração de um antagonista de il-4r
KR102473555B1 (ko) 2012-09-07 2022-12-05 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
KR102402806B1 (ko) 2012-11-05 2022-05-30 리제너론 파마슈티칼스 인코포레이티드 유전자 변형된 비-인간 동물 및 그것의 사용 방법
SI2958938T1 (sl) 2013-02-20 2019-08-30 Regeneron Pharmaceuticals, Inc. Miši, ki izražajo humanizirane koreceptorje za celice T
ES2949029T3 (es) 2013-02-22 2023-09-25 Regeneron Pharma Células murinas que expresan complejo mayor de histocompatibilidad humanizado
JO3532B1 (ar) 2013-03-13 2020-07-05 Regeneron Pharma الأجسام المضادة لمضاد انترلوكين-33 واستعمالاتها
EP2922394B1 (en) 2013-09-23 2017-02-22 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized signal-regulatory protein gene
SI2908626T1 (sl) 2013-10-15 2017-02-28 Regeneron Pharmaceuticals, Inc. Humanizirane živali IL-15
CN105792646B (zh) 2013-11-19 2018-03-02 瑞泽恩制药公司 具有人源化的b细胞活化因子基因的非人动物
US20150143559A1 (en) 2013-11-19 2015-05-21 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
PL3129400T3 (pl) 2014-04-08 2020-09-07 Regeneron Pharmaceuticals, Inc. Zwierzęta inne niż człowiek mające humanizowane receptory fc-gamma
ES2779070T3 (es) 2014-05-05 2020-08-13 Regeneron Pharma Animales con C5 y C3 humanizadas
NO2785538T3 (el) * 2014-05-07 2018-08-04

Also Published As

Publication number Publication date
IL297105A (en) 2022-12-01
IL304841A (en) 2023-09-01
LT3281521T (lt) 2021-09-27
AU2015255977A1 (en) 2016-11-17
PH12016502058A1 (en) 2017-01-09
IL248358B2 (en) 2023-03-01
JP7145250B2 (ja) 2022-09-30
MX370672B (es) 2019-12-19
US20150320022A1 (en) 2015-11-12
CN110269047B (zh) 2021-11-02
KR20160150637A (ko) 2016-12-30
US20170311580A1 (en) 2017-11-02
RU2016143376A3 (el) 2018-11-22
CN106470545A (zh) 2017-03-01
RS57073B1 (sr) 2018-06-29
KR102517112B1 (ko) 2023-04-03
CN110269047A (zh) 2019-09-24
ES2887852T3 (es) 2021-12-28
US11963521B2 (en) 2024-04-23
RU2703139C2 (ru) 2019-10-15
US20180000056A1 (en) 2018-01-04
JP6640740B2 (ja) 2020-02-05
JP2020058379A (ja) 2020-04-16
CA3207834A1 (en) 2015-11-12
RU2016143376A (ru) 2018-06-09
MX2016014563A (es) 2017-02-23
US20200022344A1 (en) 2020-01-23
KR102473565B1 (ko) 2022-12-02
EP3027015A1 (en) 2016-06-08
PL3281521T3 (pl) 2022-01-03
JP2022171841A (ja) 2022-11-11
PL3027015T3 (pl) 2018-04-30
HUE038028T2 (hu) 2018-09-28
IL297105B1 (en) 2023-09-01
EP3027015B1 (en) 2017-11-08
US10588298B2 (en) 2020-03-17
IL248358A0 (en) 2016-11-30
US9565841B2 (en) 2017-02-14
EP3281521A1 (en) 2018-02-14
JP6838131B2 (ja) 2021-03-03
AU2015255977B2 (en) 2021-09-02
NO2785538T3 (el) 2018-08-04
US20150320021A1 (en) 2015-11-12
CN106470545B (zh) 2019-08-20
RU2019131253A (ru) 2019-12-06
AU2021218060A1 (en) 2021-09-09
SI3281521T1 (sl) 2021-11-30
AU2021218060B2 (en) 2024-04-11
JP2017514501A (ja) 2017-06-08
JP2021087434A (ja) 2021-06-10
KR20220165814A (ko) 2022-12-15
LT3027015T (lt) 2018-01-25
CA2947307A1 (en) 2015-11-12
US20230027494A1 (en) 2023-01-26
SG10201912354PA (en) 2020-02-27
ES2656529T3 (es) 2018-02-27
IL248358B (en) 2022-11-01
EP3281521B1 (en) 2021-06-30
US10477842B2 (en) 2019-11-19
US11109578B2 (en) 2021-09-07
HUE055860T2 (hu) 2021-12-28
RS62345B1 (sr) 2021-10-29
HRP20211455T1 (hr) 2022-01-07
CA2947307C (en) 2023-09-26
US20210368753A1 (en) 2021-12-02
US9743647B2 (en) 2017-08-29
DK3281521T3 (da) 2021-09-20
EP3906781A1 (en) 2021-11-10
SI3027015T1 (en) 2018-02-28
IL297105B2 (en) 2024-01-01
WO2015171861A1 (en) 2015-11-12
PT3027015T (pt) 2018-02-09
PT3281521T (pt) 2021-09-16
DK3027015T3 (en) 2018-01-22
CY1119773T1 (el) 2018-06-27
HRP20180242T1 (hr) 2018-03-09
BR112016025745A2 (pt) 2018-01-16
SG11201608570YA (en) 2016-11-29

Similar Documents

Publication Publication Date Title
CY1124605T1 (el) Ζωα με εξανθρωπισμενα il-4 και il-4r αλφα
CY1122940T1 (el) Μη ανθρωπινα ζωα που εχουν ενα εξανθρωπισμενο γονιδιο προγραμματισμενου κυτταρικου θανατου 1
CY1119071T1 (el) Εξανθρωποποιημενα il-7 τρωκτικα
CY1124171T1 (el) Μη ανθρωπινα ζωα με εξανθρωπισμενο γονιδιο ενεργοποιησης λεμφοκυτταρων 3
CY1121410T1 (el) Μη-ανθρωπινα ζωα που εχουν ενα εξανθρωποποιημενο γονιδιο ρυθμιστικης πρωτεϊνης σηματος
CY1121405T1 (el) Εξανθρωποποιημενα il-15 ζωα
CY1123723T1 (el) Μη ανθρωπινα ζωα που φερουν ενα εξανθρωπισμενο γονιδιο συμπλεγματος διαφοροποιησης 274
CY1124320T1 (el) Ανθρωποποιημενα μη ανθρωπινα ζωα με περιορισμενους τοπους βαριας αλυσιδας ανοσοσφαιρινης
CY1124089T1 (el) Μη ανθρωπινα ζωα που εχουν ενα εξανθρωπισμενο γονιδιο συμπλεγματος διαφοροποιησης 47
CY1122820T1 (el) Ποντικοι adam6
CY1121223T1 (el) Ποντικοι οι οποιοι εκφραζουν ανθρωποποιημενο μειζον συμπλεγμα ιστοσυμβατοτητας
CY1122833T1 (el) Ογκολυτικος αδενοϊος που κωδικοποιει μια πρωτεϊνη β7
CO2019006541A2 (es) Administración viral de neoantígenos
CY1123215T1 (el) Πολυνουκλεοτιδια τα οποια κωδικοποιουν αντισωματα τρωκτικων με ανθρωπινους ιδιοτυπους και ζωα τα οποια διαθετουν αυτα
PE20191842A1 (es) Vectores de neoantigeno de alfavirus
MX2016014504A (es) Animales c5 y c3 humanizados.
JP2014039567A5 (el)
CY1123405T1 (el) Κυτταρα θηλαστικου που εκφραζουν αντιγονα κυτταρομεγαλοϊου
EP3507373A4 (en) GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERAL PD-L1
CY1123046T1 (el) Ζωα εκτος του ανθρωπου που εχουν ανθρωποποιημενους υποδοχεις fc-γ
IL271454A (en) Rapid single-cell genetic sequencing with low aggregation bias
PH12016502170A1 (en) Humanized dipeptidyl peptidase iv (dpp4) animals
MY183189A (en) Non-human animals having a humanized a proliferation-inducing ligand gene
CY1123793T1 (el) Γονιδιακη θεραπεια rpgr για μελαγχρωστικη αμφιβληστροειδοπαθεια
EP3507376A4 (en) GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH A HUMAN OR CHIMERIC TIGIT